Kolopp M - Search Results

1

The minipig in dermatotoxicology: methods and challenges.

Mahl JA, Vogel BE, Court M, Kolopp M, Roman D, Nogués V. Mahl JA, et al. Among authors: kolopp m. Exp Toxicol Pathol. 2006 Jul;57(5-6):341-5. doi: 10.1016/j.etp.2006.03.004. Epub 2006 May 19. Exp Toxicol Pathol. 2006. PMID: 16713702

2

LAV694, a new antiproliferative agent showing improved skin tolerability vs. clinical standards for the treatment of actinic keratosis.

Medina J, Picarles V, Greiner B, Elsaesser C, Kolopp M, Mahl A, Roman D, Vogel B, Nussbaumer P, Winiski A, Meingassner J, Fraissinette Ade B. Medina J, et al. Among authors: kolopp m. Biochem Pharmacol. 2003 Nov 15;66(10):1885-95. doi: 10.1016/s0006-2952(03)00369-1. Biochem Pharmacol. 2003. PMID: 14599546

3

Assessment of the phototoxic potential of compounds and finished topical products using a human reconstructed epidermis.

Medina J, Elsaesser C, Picarles V, Grenet O, Kolopp M, Chibout SD, de Brugerolle de Fraissinette A. Medina J, et al. Among authors: kolopp m. In Vitr Mol Toxicol. 2001 Fall;14(3):157-68. doi: 10.1089/109793301753407920. In Vitr Mol Toxicol. 2001. PMID: 11846989

4

Use of human skin equivalent Apligraf for in vitro assessment of cumulative skin irritation potential of topical products.

Medina J, de Brugerolle de Fraissinette, Chibout SD, Kolopp M, Kammermann R, Burtin P, Ebelin ME, Cordier A. Medina J, et al. Among authors: kolopp m. Toxicol Appl Pharmacol. 2000 Apr 1;164(1):38-45. doi: 10.1006/taap.1999.8875. Toxicol Appl Pharmacol. 2000. PMID: 10739742 Clinical Trial.

5

Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles.

de Brugerolle de Fraissinette, Picarles V, Chibout S, Kolopp M, Medina J, Burtin P, Ebelin ME, Osborne S, Mayer FK, Spake A, Rosdy M, De Wever B, Ettlin RA, Cordier A. de Brugerolle de Fraissinette, et al. Among authors: kolopp m. Cell Biol Toxicol. 1999 Apr;15(2):121-35. doi: 10.1023/a:1007577515215. Cell Biol Toxicol. 1999. PMID: 10408359

6

Poly(ethylene carbonate)s, part II: degradation mechanisms and parenteral delivery of bioactive agents.

Stoll GH, Nimmerfall F, Acemoglu M, Bodmer D, Bantle S, Müller I, Mahl A, Kolopp M, Tullberg K. Stoll GH, et al. Among authors: kolopp m. J Control Release. 2001 Oct 19;76(3):209-25. doi: 10.1016/s0168-3659(01)00417-5. J Control Release. 2001. PMID: 11578737

7

Morphologic and immunohistochemical characterization of Leydig cell tumor variants in Wistar rats.

Qureshi SR, Perentes E, Ettlin RA, Kolopp M, Prentice DE, Frankfurter A. Qureshi SR, et al. Among authors: kolopp m. Toxicol Pathol. 1991;19(3):280-6. doi: 10.1177/019262339101900311. Toxicol Pathol. 1991. PMID: 1723533

8

The presence of drug in control samples during toxicokinetic investigations--a Novartis perspective.

Nicholls I, Kolopp M, Pommier F, Scheiwiller M. Nicholls I, et al. Among authors: kolopp m. Regul Toxicol Pharmacol. 2005 Jul;42(2):172-8. doi: 10.1016/j.yrtph.2005.03.004. Regul Toxicol Pharmacol. 2005. PMID: 15885865

9

In vitro tolerability of human nasal mucosa: histopathological and scanning electron-microscopic evaluation of nasal forms containing Sandostatin.

de Fraissinette A, Kolopp M, Schiller I, Fricker G, Gammert C, Pospischil A, Vonderscher J, Richter F. de Fraissinette A, et al. Among authors: kolopp m. Cell Biol Toxicol. 1995 Oct;11(5):295-301. doi: 10.1007/BF00757627. Cell Biol Toxicol. 1995. PMID: 8608410

10

In situ analysis of adenohypophysis proliferative activity in beagle dogs. Preliminary results.

Kolopp M, Poirel G, Vit P, Perentes E. Kolopp M, et al. Pathol Res Pract. 1992 Jun;188(4-5):663-7. doi: 10.1016/S0344-0338(11)80076-2. Pathol Res Pract. 1992. PMID: 1409108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page